Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WASH and IL9R antisense RNA 1 (WASIR1) is a long non-coding RNA (lncRNA) gene, meaning it is transcribed into RNA but does not encode a protein[1][4]. Antisense lncRNAs like WASIR1 can regulate gene expression, often by interacting with nearby genes (such as WASH and IL9R), or through involvement in chromatin structure and RNA/protein scaffold functions[1][2]. The precise biological roles and clinical significance of WASIR1 remain poorly characterized, and it is not recognized as a therapeutic target. There are currently no drugs, mechanisms of action, or validated biomarker uses associated with this lncRNA. Its function aligns with the general properties of non-coding RNAs, such as regulation of transcription, chromatin remodeling, and possibly indirect effects on nearby gene expression[1][2][4].
Not applicable (no known drugs target WASIR1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WASH and IL9R antisense RNA 1 (WASIR1).